Under way, not recruiting

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

NCT05696444 · Medtronic - MITG · Updated 25 Nov 2025

What is being tested: RAS Prostatectomy; RAS Cystectomy; RAS Nephrectomy
For: Bladder Cancer; Prostate Cancer; Kidney Cancer; Pelvic Tumor; Interstitial Cystitis; Congenital Abnormalities; End Stage Renal Disease; Renal Tumor; Kidney Injury
Kind of study: Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join: Ages 22 years and older. About 144 people. The full rules are on the registry page.
Where: United States (6 sites)
When: Starts or started 14 Dec 2022, ends 31 Jan 2030. Registered 25 Jan 2023.
Results: Posted on the registry on 25 Nov 2025.

In the researchers' words

This study will evaluate the safety and performance of the Medtronic Hugo™ RAS System when used for urologic RAS procedures.

Sites